Ipca Laboratories’ arm acquires 80% stake in Bayshore

03 Oct 2018 Evaluate

Ipca Laboratories’ wholly owned subsidiary -- Ipca Pharmaceuticals Inc., USA has acquired 80% share capital of Bayshore Pharmaceuticals LLC (Bayshore), a New Jersey liability company on October 2, 2018, for cash of $10.286 million. The acquired company belongs to Sales and Marketing of FDA approved Generics Drug Products in the United States of America.

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1459.30 2.15 (0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×